Press page ASC Oncology

Welcome to the press page of ASC Oncology. Here we provide our press releases, press pictures and all important information about who we are and what we do.

Publications

Berlin Partner reports on ASC Oncology as a pioneer in modern cancer research and on the Reverse Clinical Engineering®, which makes advances in modern cancer research accessible to patients in the sense of personalized treatment.

August 2023

EU Startup News is calling ASC Oncology one of the 15 Biotechnology Startups with biotech breakthroughs. The “reverse clinical engineering supports both patients and physicians, showcasing a unique approach in biotech health diagnostics and therapeutics.”

June 2023

SelectScience talked to our CEO Dr Christian. Regenbrecht about bringing targeted tumor therapy to patients and the promising future of patient-derived tumor organoids.

April 2021

berlin-buch.com reports about the collaboration of Maya Niethard, MD (Sarcoma Center Helios-Hospital Berlin Buch) and Christian Regenbrecht, PHD (ASC Oncology / Cellphenomics).

January 2021

Dr. Christian Regenbrecht was a guest at the podcast “The Culture Club” and talked about 3D cell culture technologies, preclinical efficacy studies, and the changing healthcare landscape.

December 2019

Dr. Regenbrecht speaks on the Youtube channel of the Rotary Club about the treatment of cancer and the Non For Profit Organization/Network “Scientists without Borders”.

October .2014

Press releases

2022-11-01

Cancer does not stop at borders – and neither does an approach to personalized cancer therapy developed in Berlin. Reverse Clinical Engineering® is now available to oncologists and cancer patients in Saudi Arabia, the Middle East, and North Africa.

2021-03-24

Knowing what works: Thanks to a new test procedure before the start of therapy, ASC Oncology can answer the crucial question posed by both patients and oncologists of how effective cancer drugs will be on each patient’s tumor.

Press materials

Press kit

Press pictures

Logo

You have questions, would like to learn more about ASC Oncology or are looking for an interview partner? Please don’t hesitate to write us an email to presse@asc-oncology.com.

Press materials

Press kit

Press pictures

Logo

Your contact partner

Please feel free to contact me in case of having any further questions of if you are interested in an interview. You can reach me from Monday to Friday between 9am and 6pm.

Melanie Alperstaedt

Corporate Communication

Collaborations

Press page ASC Oncology

Publications

Berlin Partner reports on ASC Oncology as a pioneer in modern cancer research and on the Reverse Clinical Engineering®, which makes advances in modern cancer research accessible to patients in the sense of personalized treatment.

August 2023

EU Startup News is calling ASC Oncology one of the 15 Biotechnology Startups with biotech breakthroughs. The “reverse clinical engineering supports both patients and physicians, showcasing a unique approach in biotech health diagnostics and therapeutics.”

June 2023

SelectScience talked to our CEO Dr Christian. Regenbrecht about bringing targeted tumor therapy to patients and the promising future of patient-derived tumor organoids.

April 2021

berlin-buch.com reports about the collaboration of Maya Niethard, MD (Sarcoma Center Helios-Hospital Berlin Buch) and Christian Regenbrecht, PHD (ASC Oncology / Cellphenomics).

January 2021

Dr. Christian Regenbrecht was a guest at the podcast “The Culture Club” and talked about 3D cell culture technologies, preclinical efficacy studies, and the changing healthcare landscape.

December 2019

Dr. Regenbrecht speaks on the Youtube channel of the Rotary Club about the treatment of cancer and the Non For Profit Organization/Network “Scientists without Borders”.

October .2014

Press releases

2022-11-01

Cancer does not stop at borders – and neither does an approach to personalized cancer therapy developed in Berlin. Reverse Clinical Engineering® is now available to oncologists and cancer patients in Saudi Arabia, the Middle East, and North Africa.

2021-03-24

Knowing what works: Thanks to a new test procedure before the start of therapy, ASC Oncology can answer the crucial question posed by both patients and oncologists of how effective cancer drugs will be on each patient’s tumor.

Press materials

Press kit

Press pictures

Logo

Press materials

Press kit

Press pictures

Logo

Your contact partner

Melanie Alperstaedt

Collaborations

ASC Oncology

Social Media

Newsletter

Contact

siilo.

Press page ASC Oncology

Publications

Berlin Partner reports on ASC Oncology as a pioneer in modern cancer research and on the Reverse Clinical Engineering®, which makes advances in modern cancer research accessible to patients in the sense of personalized treatment.

August 2023

EU Startup News is calling ASC Oncology one of the 15 Biotechnology Startups with biotech breakthroughs. The “reverse clinical engineering supports both patients and physicians, showcasing a unique approach in biotech health diagnostics and therapeutics.”

June 2023

SelectScience talked to our CEO Dr Christian. Regenbrecht about bringing targeted tumor therapy to patients and the promising future of patient-derived tumor organoids.

April 2021

berlin-buch.com reports about the collaboration of Maya Niethard, MD (Sarcoma Center Helios-Hospital Berlin Buch) and Christian Regenbrecht, PHD (ASC Oncology / Cellphenomics).

January 2021

Dr. Christian Regenbrecht was a guest at the podcast “The Culture Club” and talked about 3D cell culture technologies, preclinical efficacy studies, and the changing healthcare landscape.

December 2019

Dr. Regenbrecht speaks on the Youtube channel of the Rotary Club about the treatment of cancer and the Non For Profit Organization/Network “Scientists without Borders”.

October .2014

Press releases

2022-11-01

Cancer does not stop at borders – and neither does an approach to personalized cancer therapy developed in Berlin. Reverse Clinical Engineering® is now available to oncologists and cancer patients in Saudi Arabia, the Middle East, and North Africa.

2021-03-24

Knowing what works: Thanks to a new test procedure before the start of therapy, ASC Oncology can answer the crucial question posed by both patients and oncologists of how effective cancer drugs will be on each patient’s tumor.

Press materials

Press kit

Press pictures

Logo

Press materials

Press kit

Press pictures

Logo

Your contact partner

Melanie Alperstaedt

Collaborations

ASC Oncology

Social Media

Newsletter

Contact

siilo.

Subscribe To Our Weekly Newsletter